SPIRIVA HandiHaler Recall: Foreign Substance in Capsules
Boehringer Ingelheim recalls SPIRIVA HandiHaler capsules due to potential foreign particles. Check lot numbers and expiration dates for affected batches.
Use caution until it’s fixed
Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler
Contact the company
What happened, in plain English
Boehringer Ingelheim Roxane Inc is recalling SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules because of the potential presence of extrinsic foreign particles in the active pharmaceutical ingredient. The recall affects specific lots distributed nationwide, with expiration dates ranging from September 2013 through July 2014. Consumers should check their medication against the listed lot numbers to determine if they are affected. Read more at govinfonow.com/recall/46648-boehringer-ingelheim-roxane-inc-recalls-spiriva-handihaler-tiotropium-bromide-inhalation.
Source Summary by GovInfoNow · govinfonow.com/recall/46648-boehringer-ingelheim-roxane-inc-recalls-spiriva-handihaler-tiotropium-bromide-inhalation · Updated October 13, 2026 · FDA enforcement record: FDA #D-1057-2013
Cite this page
“SPIRIVA HandiHaler Recall: Foreign Substance in Capsules.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46648-boehringer-ingelheim-roxane-inc-recalls-spiriva-handihaler-tiotropium-bromide-inhalation. Based on FDA recall #D-1057-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1057-2013%22&limit=1).
Why it’s dangerous
The hazard involves extrinsic foreign particles potentially present in the API used to manufacture the capsules. Inhaling these foreign substances could pose a health risk, although the record does not specify the exact nature or severity of injuries that might result from exposure.
Who’s affected
Patients who have been prescribed SPIRIVA HandiHaler for respiratory conditions and purchased the recalled lots between August 2013 and July 2014. Individuals with these specific lot numbers are at risk of inhaling foreign particles.
How to tell if you have this one
Look for SPIRIVA HandiHaler Capsules 18 mcg per dose in 10, 30, 90 count blisters or physician samples. Check the NDC numbers (0597-0075-27, 0597-0075-41, 0597-0075-47, 0597-0075-75) and verify if your lot number matches the list provided in the record, such as 202477A/Sep-13 or 301867A/Aug-14.
- Brand
Boehringer Ingelheim- Category
Drug
What to do — step by step
Check Your Lot Number
Compare the lot number and expiration date on your SPIRIVA HandiHaler package against the specific lots listed in the recall record.
Contact Your Pharmacist
If you have an affected product, contact your pharmacist or healthcare provider for instructions on how to return or dispose of the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Which lot numbers are affected by this recall?
Affected lots include 202477A/Sep-13, 202480A/Sep-13, 202556B/Sep-13, 202603A/Sep-13, 202784B/Sep-13, 202844A/Sep-13, 202951A/Sep-13, 203041A/Sep-13, 203042A/Sep-13, 203280A/Oct-13, 203281A/Oct-13, 203364A/Oct-13, 203440A/Oct-13, 203569B/Oct-13, 203588A/Oct-13, 203890B/Nov-13, 204094A/Nov-13, 203660A/Nov-13, 203690A/Nov-13, 203890A/Nov-13, 203980A/Nov-13, 203981B/Nov-13, 204356B/Dec-13, 204357A/Dec-13, 204821A/Dec-13, 204459A/Dec-13, 204552C/Dec-13, 204822A/Dec-13, 204944A/Jan-14, 204947A/Jan-14, 205015A/Jan-14, 205163A/Jan-14, 205364A/Jan-14, 205509A/Feb-14, 205737A/Feb-14, 205571A/Feb-14, 205572A/Feb-14, 205674A/Feb-14, 205682A/Feb-14, 205959A/Feb-14, 205987A/Feb-14, 206186B/Mar-14, 206311A/Mar-14, 206606A/Mar-14, 206944B/Apr-14, 207066A/Apr-14, 206609A/Apr-14, 206729A/Apr-14, 206899A/Apr-14, 206900A/Apr-14, 207065B/Apr-14, 207191A/May-14, 207199A/May-14, 207352A/May-14, 207420A/May-14, 207577B/May-14, 207691A/May-14, 207692A/May-14, 207778A/May-14, 207818A/Jun-14, 301378A/Jul-14, 301476B/Jul-14, 301699B/Jul-14, 301867A/Aug-14, 202530/Sep-13, 203195A/Oct-13, 203366C/Nov-13, 204067A/Nov-13, 204460B/Dec-13, 204551A/Dec-13, 205260A/Jan-14, 206064B/Mar-14, 206185A/Mar-14, 206939A/Apr-14, 207038A/May-14, 301699A/Jul-14, 202556A/Sep-13, 203569A/Oct-13, 203981A/Nov-13, 204674A/Dec-13, 205737B/Feb-14, 206944A/Apr-14, 207577A/May-14, 301476A/Jul-14. Physician samples include 203076A/Oct-13, 203891A/Nov-13, 204674B/Dec-13, 205867A/Feb-14, and 206731A/Apr-14.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1057-2013 (August 30, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1057-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.